Chaim Indig Sells 3,392 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CEO Chaim Indig sold 3,392 shares of Phreesia stock in a transaction dated Monday, April 15th. The shares were sold at an average price of $22.86, for a total value of $77,541.12. Following the sale, the chief executive officer now owns 1,222,005 shares of the company’s stock, valued at approximately $27,935,034.30. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Chaim Indig also recently made the following trade(s):

• On Monday, April 8th, Chaim Indig sold 12,043 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total value of $272,412.66.

Phreesia Stock Performance

NYSE PHR opened at $22.62 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. The business has a 50-day moving average price of $24.40 and a 200-day moving average price of $21.26. Phreesia, Inc. has a twelve month low of $12.05 and a twelve month high of $34.98.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) EPS for the quarter, beating analysts’ consensus estimates of ($0.58) by $0.02. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. The company had revenue of $95.00 million during the quarter, compared to analyst estimates of $93.52 million. During the same period in the prior year, the company earned ($0.72) earnings per share. The firm’s revenue was up 24.0% on a year-over-year basis. Equities analysts predict that Phreesia, Inc. will post -1.48 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on PHR. Barclays initiated coverage on Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective on the stock. Robert W. Baird lifted their price objective on Phreesia from $30.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, March 18th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research report on Thursday, March 21st. Canaccord Genuity Group lifted their price target on Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Finally, JMP Securities boosted their target price on Phreesia from $28.00 to $30.00 and gave the stock a “market outperform” rating in a report on Thursday, March 21st. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Phreesia currently has a consensus rating of “Moderate Buy” and an average target price of $31.62.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. Envestnet Asset Management Inc. raised its position in Phreesia by 11.7% during the first quarter. Envestnet Asset Management Inc. now owns 9,692 shares of the company’s stock valued at $255,000 after purchasing an additional 1,015 shares during the period. JPMorgan Chase & Co. boosted its position in Phreesia by 160.9% during the 1st quarter. JPMorgan Chase & Co. now owns 85,546 shares of the company’s stock valued at $2,254,000 after acquiring an additional 52,755 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in Phreesia by 20.7% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 8,427 shares of the company’s stock valued at $222,000 after acquiring an additional 1,447 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Phreesia by 0.9% in the 1st quarter. Bank of New York Mellon Corp now owns 219,598 shares of the company’s stock worth $5,788,000 after purchasing an additional 2,047 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its position in shares of Phreesia by 27.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 16,059 shares of the company’s stock worth $424,000 after purchasing an additional 3,473 shares in the last quarter. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.